Respondents had lower odds of accepting infant mAb (OR: 0.10, 95% CI: 0.07–0.15) and maternal RSV vaccine (OR: 0.16, 95% CI: 0.12–0.23) if they were somewhat or very concerned about side effects. Respondents had higher odds of accepting infant mAb if they received an influenza ...
People infected are usually contagious for three to eight days. Babies and people with weakened immune systems can spread RSV for up to four weeks. There is no vaccine for it, though several candidates are in testing. WHO DOES IT AFFECT? Everyone can get RSV. But it causes the...
A sign stands outside Seattle Children's Hospital on March 18, 2020, in Seattle. Children's hospitals in parts of the country are seeing a distressing surge in RSV, a common respiratory illness that can cause severe breathing problems for babies. Cases fell dramatically two years ago as the ...
Measuring neutralising activity in serum is a common tool towards assessing the immunogenicity of vaccine candidates. RSV neutralisation assays vary greatly between laboratories and it is a challenge to accurately compare RSV serum neutralisation titres across multiple formats, laboratories and clinical ...
VaccinePreterm birthBackground: Respiratory syncytial virus (RSV) is the most important viral cause of pneumonia in children. RSV-specific antibody (ab) protects infants from disease, and may be increased by a potential strategy of maternal RSV vaccination.Chu, Helen Y.Tielsch, JamesKatz, Joanne...
People infected are usually contagious for three to eight days. Babies and people with weakened immune systems can spread RSV for up to four weeks. There is no vaccine for it, though several candidates are in testing. WHO DOES IT AFFECT?